If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Cancellation of warrants

3 Jul 2013 07:00

RNS Number : 4539I
Silence Therapeutics PLC
03 July 2013
 



 

Silence Therapeutics plc ("Silence" or the "Company")

 

CANCELLATION OF WARRANTS

 

03 July 2013

 

 

The Company has agreed to buy back and cancel the 66,600 warrants, exercisable at 75p, issued to Darwin Strategic Ltd for a payment of £70,000. This was the fair value of the warrants on 4 June 2013, the date Silence published its annual report. Darwin is 37% owned by Ali Mortazavi, the chief executive of Silence.

 

For further information please contact:

 

Silence Therapeutics

Ali Mortazavi, chief executive/Timothy Freeborn, finance director +44 (0)333 988 0140

a.mortazavi@silence-therapeutics.com

t.freeborn@silence-therapeutics.com

 

N+1 Singer

Shaun Dobson/Jenny Wyllie

+44 20 7496 3000

shaun.dobson@n1singer.com

jenny.wyllie@n1singer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVRDEIFIIV

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS